Publication
Testosterone monitoring and supplementation in patients with intermediate- or high-risk prostate cancer treated with 6-36 months of androgen deprivation therapy and radiotherapy: a systematic literature review.
Vérane Achard, Almuneda Zapatero, Amar U Kishan, Pierre Blanchard, Lisa G Horvath, Barbara A Jereczek-Fossa, Bertrand Tombal
- Source
- PubMed
- Retrieved
- Sep 14, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260914-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
Androgen deprivation therapy (ADT) combined with curative-intent radiotherapy is a cornerstone for intermediate- and high-risk localised prostate cancer, yet the clinical relevance of testosterone (T) monitoring and the safety of testosterone replacement therapy (TRT) in patients with persistent…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Prostate Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available